ibrutinib
Ibrutinib is a medication used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting a specific enzyme called Bruton's tyrosine kinase, which is essential for cancer cell growth and survival. By blocking this enzyme, ibrutinib helps to stop cancer cells from proliferating, allowing the immune system to better fight the disease. It's typically taken as a daily pill and can help improve the prognosis for patients with these conditions, though it may have side effects that need to be managed.
Additional Insights
-
Ibrutinib is a medication used primarily to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. It works by blocking a specific protein called BTK, which is important for cancer cell survival and growth. By inhibiting this protein, ibrutinib helps to stop the cancer cells from multiplying and spreading. Patients take it orally, and it can be a long-term treatment option. While it can be effective, it may also have side effects, so doctors monitor patients closely during treatment.